HEOR, HTA & Outcomes Evidence

“To date, we have supported the development of over 370 health technology assessment (HTA) submission dossiers, including over 135 submission dossiers to NICE, and over 105…”

“Synthesises evidence to support HTA submissions, pricing and reimbursement decisions”

“Develop robust HEOR strategies that generate credible, stakeholder-aligned evidence to meet the rigorous expectations of payers, HTA organizations, policymakers, and health care…”

“We support HTA from start to finish, from access strategy, advisory workshops, submission drafting, modelling, preparation for negotiations and post-submission activities, working…”

“We provide health economic modeling at every stage of the drug development process.”

“Handling local HTA and pricing & reimbursement processes, guiding local negotiations”

“Build comprehensive, evidence-based submissions tailored to national and regional HTA bodies.”

“Deliver the right evidence to demonstrate your product’s value and address regulator and payer requests efficiently.”

“Develop robust evidence-generation roadmaps and execute key HEOR initiatives, including literature reviews, dossiers, burden of illness studies, and stakeholder research.”

“Flexible RWD simulations and real-world analytics enabled label expansion, clinical guideline updates, and economic models for payer engagement, strengthening scientific…”

“Run cost-effectiveness studies of varying interventions, support post-market surveillance, and boost HEOR studies.”

“ZS helps R&D organizations with integrated evidence strategy, planning and generation. Our solutions like ZS Evidence Pro empower you to adopt the multidisciplinary approach that…”

“Identify unmet needs, assess disease burden and progression, and make smarter internal decisions with robust R&D studies informed by real-world data.”

“We incorporate patient-reported outcome measures into our real-world studies to capture the patient experience — quality of life, treatment satisfaction, symptom burden —…”

“Gain insight into the cost-effectiveness of treatments by comparing costs and benefits. Our custom reporting makes it simple to evaluate economic data and determine the value of…”

“Take your health economics outcomes research (HEOR) to the next level by linking your siloed real-world datasets.”

“…Supported by AI-enabled technology to enhance insight, speed, and consistency, our services include integrated evidence strategy and literature reviews, robust global and local…”

“We use customized healthcare economic modeling tools that demonstrate value by aligning clinical benefit with relevant cost impact. Our tools allow formulary decision-makers to…”

“…Access Evidence Planning”

“Veristat Market Access team members provide strategic advice on national early access programs, write HTA/reimbursement dossiers for submission to national HTA bodies and prepare…”